Lunasin exhibits immunomodulatory activity against cancer, specifically through combining with cytokines interleukin-2 (IL-2) and interleukin-12 (IL-12); this combination has a synergistic effect that stimulates natural killer (NK) cells to enhance interferon gamma (IFNγ) production [18]. The gene discussed is IFNG; the disease is cancer.